Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System WIth Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System
